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Human body is designed to maintain a complex network of vasculature that is capable of continuously circulating blood for decades. It is also liable for its own repair when internal or external forces disturb the integrity of this system. Blood coagulation means conversion of fluid blood to a solid clot or gel-like structure. The conversion of soluble fibrinogen to insoluble fibrin is the main event of blood coagulation cascade [1] . Anticoagulants are used for the prevention and treatment of venous and arterial thromboembolism [2] . Thrombotic disorders are the underlying cause of 38% of all non-communicable disease related deaths worldwide. Thrombosis is a common pathology underlying ischemic heart disease, ischemic stroke, and venous thromboembolism (VTE). The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study 2010 documented that ischemic heart disease and stroke collectively caused one in four deaths worldwide. Factor IXa (FIXa) is also known as Christmas factor, which is a serine protease family enzyme of coagulation cascade discovered in 1952 by Christmas [3] . FIXa is synthesized in liver, which plays an important role in the blood coagulation [4] . Warfarin is the only orally active anticoagulant, which is clinically used nowadays. As it has a narrow therapeutic window and various side effects dose monitoring is required for warfarin [5] . Ximelagatran was the first oral direct thrombin inhibitor and had confirmed efficacy for prevention and treatment of VTE, stroke prevention and recurrent coronary events after acute myocardial infarction. But it was withdrawn by AstraZeneca in the year 2006 because of liver toxicity [6, 7] . However, the new drugs available are still far away from fulfilling the desired objectives because, currently available anticoagulant therapy faces some limitations including inability to inhibit the clot-bound thrombin, variable patient responses, heparin-induced thrombocytopenia (HIT) and the enhanced chance of bleeding [8] . Hence design and development of newer anticoagulant agents with drug-like properties close to that of ideal antithrombotic agent is still a challenge. 3D quantitative structure-activity relationship models (QSAR) and k-nearest neighbor molecular field analysis (kNN-MFA) approach uses sampling based on methyl probe of charge +1, within the molecular lattice to determine the molecular properties particularly steric and electrostatic properties and their correlation with the biological activity. Pharmacophore is defined as the structural features, which are responsible for the biological activity of the molecules. The various interaction points are categorized as, hydrogen bond donor, hydrophobic and steric interaction points [8, 9] . Here we studied the 3D QSAR, kNN-MFA analysis and pharmacophore modelling of some FIXa inhibitors, which would further give insight into structural features requirements for design and development of new FIXa inhibitors as antithrombotic class of drug.
MATERIALS AND METHODS
Dataset for the present study was taken from the literature reported by Parker et al. [10] . The data set was assorted into a training set (16 molecules) and a test set (7 molecules) using random selection. Structures and inhibitory activity listed in Table 1 .
QSAR analysis:
The structures of benzimidazole substituents were drawn using 2D draw module in draw module of Vlife MDS 4.3 and converted them into 3D structures. Merck molecular force field (MMFF) and Gasteiger charges were utilized for the energy minimization to optimize ligand geometries till an energy gradient of 0.001 kcal/mol was reached with 10 000 number of cycles and 0.01 as convergence criteria (rms gradient) [11, 12] . All the molecules of the present data set were aligned by the template-based technique, using the common structure of benzimidazole as template with the help of VLife MDS 4.3 and most active molecule (S. no. 22 having Ki 0.016 µM) as reference for alignment of molecules. Alignment of all the molecules is shown in fig. 1A and template used for that is shown in fig. 1B . Same as other 3D QSAR methods, kNN-MFA also needs proper alignment of molecules. A suitable alignment of the given set of molecules was performed by using the Vlife MDS 4.3 engine. This is followed by generation of a common rectangular grid around the molecules. The steric, electrostatic and hydrophilic interaction energies for 3D QSAR and the steric and electrostatic energies were computed for kNN-MFA at the lattice points of the grid using methyl probe of charge +1. The values of these interaction energies were employed as values of 3D descriptors for correlation with bioactivity of the molecules. On the basis of biological and chemical variety, the data set was divided into a test set and training set using random selection. The bioactivity was expressed as inhibitory concentration (Ki µM) for FIXa inhibition was for the present 3D-QSAR, kNN-MFA and pharmacophore study.
3D-QSAR model:
To correlate relationship between independent 3D fields and dependent bioactivity variables was determined using multiple linear regression (MLR) analysis and r 2 was used to describe the fitness of data, models having correlation coefficient above 0.8 were used to check the external predictability whereas significance of the model was determined by F value. While those models show q 2 below 0.7 were discarded. The selected models for FIXa are shown in Table 2 and fig. 2A showing the field points of QSAR model A.
kNN-MFA model:
An optimal training and test set can be generated for kNN method using random selection algorithm. kNN methodology was applied to the descriptors generated over the grid after the training and test sets were generated. To generate 3D-QSAR equations kNN-MFA with stepwise variable selection method was used [13] . Models having q 2 above 0.8 were used to check the external predictivity while the models showing q 2 below 0.6 were discarded. The selected models are shown in Table 3 and fig. 2B showing field points of kNN-MFA model A.
To thoroughly measure a QSAR model, a reliable validation is necessary. Generally, QSAR model is evaluated by the predicted activity of given dataset. Selected models for 3D QSAR and kNN-MFA having value above 0.8 were checked for their external predictive activity measured as predictive r 2 . The predicted and observed activity and residual values are shown in Table 4 
Fig. 2: Field points of QSAR model A (A) and kNN-MFA model A (B)
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Pharmacophore modeling:
Pharmacophore modeling was carried out in the workspace of mole sign module of Vlife MDS 4.3. Dataset of FIXa inhibitors was first aligned with reference to most active molecule as template. The minimum number of pharmacophore features for generated model was taken as 5.
RESULTS AND DISCUSSION
In this present study, 23 molecules dataset was used to generate QSAR and kNN-MFA models. The steric, electrostatic and hydrophobic field points calculated for QSAR while steric and electrostatic fields for kNN-MFA were calculated using the Tripos force field and Gasteiger-Marsili charges. After the successful running MLR, different set of equations were generated, which were further analysed to select best model. The best models were selected on the basis of values of r The structural requirements of benzimidazole derivatives as FIXa inhibition were obtained from the 3D descriptors of model A. The r 2 value for model A was found to be 0.9580 while for model B it was 0.9392. Model A was found to be best to express anticoagulant activity as selected descriptors for model A were contributing to the anticoagulant activity. Descriptors of model A could help in refining the structural features, which establish to have good correlation between bioactivity and selected descriptors. The steric interaction field points represented in green lattice at S_267 and S_355 involve that the steric interaction at these lattice points are important in bioactivity of molecules and these are required to be addressed. The steric interactions at lattice point S_267 are negatively contributing to the bioactivity of molecules, which indicate that negative steric potential is favorable for activity and therefore smaller groups or groups with less steric strain substituent group is favored in that region. So aliphatic substitution at benzimidazole ring will improve activity of the molecules. The steric interaction fields at lattice point S_355 are positively contributing to the activity of molecules, which indicate that compounds which are having relatively bulky substituent's at the 6 th position of benzimidazole ring could increase activity. The electrostatic interaction The q 2 value for model A was 0.9597 and model B has 0.9344. The fitness plot of model A showed the correlation between predicted and observed activity of training set and test set molecules this will helps in cross-validation of model shown in fig. 4B . The steric interaction field points represented in green lattice at S_258 is positively contributing to the bioactivity of molecules, which indicate that compounds having relatively bulky R-substituent at the 3, 4 and 5 th position of aromatic ring of benzimidazole be evidence for increase in activity of molecules. The electrostatic interaction at lattice point E_524 and E_536 are positively contributing to activity, which shows that positive electrostatic potential is favorable for activity. Therefore it indicates that less electronegative substituent groups are ideal at that lattice points. Groups which are electron rich or electron releasing groups increases activity of molecules.
A pharmacophore model for FIXa inhibitors was generated in the mole sign module of Vlife MDS 4.3. The distinctive features like hydrogen bond acceptor (purple colour), hydrogen bond donor (green colour), hydrophobic (buff colour) and aliphatic regions (orange colour) were observed in pharmacophoric hypothesis as shown in fig. 5 . From the generated pharmacophore model indicated importance of amino bridge for H-bond interaction with amino acids like GLY216 [10] while aromatic features were found to be responsible for pi-stacking interactions with aromatic amino acids like PHE174 and TYR215.
Present study was an attempt to identify structural features of benzimidazole derivatives for as FIXa inhibitors, which involved a computational approach using 3D QSAR, kNN-MFA and pharmacophore modelling. Output of 3D QSAR analysis indicated fields represented in blue lattice points E_1113 are positively contributing to activity, which indicates that positive electrostatic potential is favorable for activity. The contribution plot and fitness plot of model A shown in figs. 3 and 4A, respectively.
The kNN-MFA model was selected on basis of q 2 , pred. r 2 , and F and k nearest neighbor (k=2) to evaluate the activity of the dataset [12] . The r 2 , coefficient of correlation and F-test is a statistical method of comparison of two different models. The lower values of pred. r 2 , q 2 and r 2 and higher value of F test indicates good model [12, 14, 15] . Model A was found to be best to articulate anticoagulant activity of FIXa inhibition. importance of steric and electrostatic potentials towards biological activity. The occurrence of aromatic features in pharmacophoric hypothesis validated results of QSAR analysis. Thus generated QSAR model and pharmacophore hypothesis will be useful for development of the novel FIXa inhibitors.
